Diampa™ LXR

  • All Products
  • By Generic
  • By Therapeutic Segment

Diampa™ LXR

Therapeutic Segment: Anti-Diabetic

Generic Name: Empagliflozin + Linagliptin + Metformin HCl

Indication:

Diampa LXR is a combination of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.

Available as:

Tablets
  • 5mg+2.5mg+1000mg
  • 10mg+5mg+1000mg
  • 12.5mg+2.5mg+1000mg
  • 25mg+5mg+1000mg

Buy our products online.

Making lives easier, healthier, happier.

Click to Order Online